NCT04686760已完成不适用
Efficacy of Inhaled Nitroglycerin in Moderate to Severe Cases of COVID-19 Patients
University of Lahore1 个研究点 分布在 1 个国家目标入组 278 人开始时间: 2020年11月15日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 278
- 试验地点
- 1
- 主要终点
- ratio of partial pressure of oxygen in arterial blood to fraction of inhaled oxygen
研究概览
简要总结
In current analysis moderate to severely ill Covid-19 infected patients will be nebulized with nitroglycerin, and they will be compared with the standard nebulization
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed admitted cases of Covid-19 degree of illness should be moderate to severe both male and female every age group
排除标准
- •allergic to nitroglycerin sudden drop in blood pressure not given consent
研究组 & 干预措施
Nitroglycerin solution
Experimental
干预措施: Nitroglycerin (Drug)
结局指标
主要结局
ratio of partial pressure of oxygen in arterial blood to fraction of inhaled oxygen
时间窗: 5-7 days
Oxygen demand
时间窗: 5-7 days
次要结局
- Duration of hospital stay(15 days)
研究者
Muhammad Mansoor Hafeez
Doctor
University of Lahore
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19SARS (Severe Acute Respiratory Syndrome)CoronavirusNCT04306393Massachusetts General Hospital200
已完成
1 期
High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)COVID-19NCT04383002University Health Network, Toronto21
撤回
2 期
Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.Coronavirus Covid-19 Infection Variant OmicronSARS (Severe Acute Respiratory Syndrome)NCT04290871Xijing Hospital
尚未招募
2 期
Effect of Inhaled Nitric Oxide for the treatment of COVID-19RBR-8nfx26Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS
终止
2 期
Nitric Oxide Inhalation Therapy for COVID-19 Infections in the EDCOVID19NCT04338828Massachusetts General Hospital47